---
schema_version: "secwatch.filing_event.v1"
accession: "0001477932-22-009427"
form_type: "8-K"
ticker: "COSM"
cik: "0001474167"
company_name: "Cosmos Health Inc."
filed_at: "2022-12-20T23:59:59+00:00"
generated_at: "2026-06-21T01:42:59.764841+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Cosmos Health raises $32.5M in registered direct offering and private placement at $11.50/unit

## Summary
- Gross proceeds of ~$32.5M from sale of 2,828,320 shares and warrants at $11.50/unit.
- Each warrant exercisable immediately at $11.50, expires in 5 years; CEO Siokas participated.
- Net proceeds to be used for working capital and general corporate purposes.
- A.G.P./Alliance Global Partners sole placement agent; cash fee of 6.5%.

## SEC filing metadata
- accession: 0001477932-22-009427
- form_type: 8-K
- ticker: COSM
- cik: 0001474167
- company_name: Cosmos Health Inc.
- filed_at: 2022-12-20T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1474167/000147793222009427/0001477932-22-009427-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1474167/000147793222009427/cosm_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001477932-22-009427
- JSON: https://secwatch.observer/filing/0001477932-22-009427.json
- Plain text: https://secwatch.observer/filing/0001477932-22-009427.txt

## Key facts
- Material Agreements
  Cosmos Health Inc. entered into Securities Purchase Agreement with certain institutional investors valued at $32,525,680 (effective 2022-12-19).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: certain institutional investors
  - Value: $32,525,680
  - Effective: 2022-12-19
  source text: On December 19, 2022, Cosmos Health Inc. (“we,” “our,” “us,” or the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain institutional investors (the “Purchasers”), for a registered direct offering and a concurrent private placement.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1474167/000147793222009427/0001477932-22-009427-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.